EAF1 Antibody (Center) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q96JC9 |
---|---|
Clone Names | 110717048 |
Gene ID | 85403 |
---|---|
Other Names | ELL-associated factor 1, EAF1 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | EAF1 |
---|---|
Function | Acts as a transcriptional transactivator of ELL and ELL2 elongation activities. |
Cellular Location | Nucleus speckle. Nucleus, Cajal body |
Tissue Location | Strongly expressed in heart, brain, placenta, lung, liver, skeletal muscle, kidney, pancreas, spleen, prostate, testis, small intestine and colon. Poorly expressed in thymus |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
EAF1 acts as a transcriptional transactivator of ELL and ELL2 elongation activities.
References
Wan, X., et al. PLoS ONE 5 (2), E9118 (2010) :Jiang, F., et al. Cancer Lett. 253(2):265-272(2007)Sugiyama, N., et al. Mol. Cell Proteomics 6(6):1103-1109(2007)Olsen, J.V., et al. Cell 127(3):635-648(2006)Xiao, W., et al. Prostate 66(1):1-12(2006)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.